Milder disease with Omicron: is it the virus or the pre-existing immunity?

被引：109
|
作者：
Sigal, Alex [1 ,2 ,3 ]
机构：
[1] Afr Hlth Res Inst, Durban, South Africa
[2] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa
[3] Max Planck Inst Infect Biol, Berlin, Germany
来源：
NATURE REVIEWS IMMUNOLOGY | 2022年 / 22卷 / 02期
关键词：
D O I：
10.1038/s41577-022-00678-4
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
At the population level we are seeing milder disease during the Omicron wave of the SARS-CoV-2 pandemic. Is this due to the virus or pre-existing immunity, and what should we expect next?
引用
收藏
页码：69 / 71
页数：3
相关论文
共 50 条
  • [41] Overcoming Pre-Existing Humoral Immunity to AAV Using Capsid Decoys
    Mingozzi, Federico
    Anguela, Xavier M.
    Pavani, Giulia
    Chen, Yifeng
    Davidson, Robert H.
    Hui, Daniel H.
    Yazicioglu, Mustafa
    Elkouby, Liron
    Hinderer, Christian J.
    Faella, Armida
    Howard, Carolann
    Tai, Alex
    Podsakoff, Gregory M.
    Ragni, Margaret C.
    Zhou, Shangzhen
    Basner-Tschakarjan, Etiena
    Wright, J. Fraser
    High, Katherine A.
    MOLECULAR THERAPY, 2013, 21 : S45 - S45
  • [42] Pre-existing immunity to SARS-CoV-2: the knowns and unknowns
    Alessandro Sette
    Shane Crotty
    Nature Reviews Immunology, 2020, 20 : 457 - 458
  • [43] Harnessing pre-existing anti-viral immunity for tumor therapy
    Nicolas, Cuburu
    Bialkowski, Lukas
    Pontejo, Sergio
    Kim, Rina
    Bell, Alexander
    Thompson, Cynthia
    Lowy, Douglas
    Schiller, John
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [44] Pre-existing immunity to AAV overcome by in silico ancestral capsid design
    Zinn, E.
    Khaychuk, V.
    Sarkar, D.
    Carvalho, L.
    Pacouret, S.
    Morris, H.
    Plovie, E.
    Vandenberghe, Luk H.
    HUMAN GENE THERAPY, 2014, 25 (11) : A8 - A8
  • [45] Mumps outbreak in a rugby league team despite pre-existing immunity
    Chee, Karen
    Workman, Cassy
    Irvine, Susan
    Ferson, Mark J.
    MEDICAL JOURNAL OF AUSTRALIA, 2020, 213 (05) : 225 - +
  • [46] Pre-existing immunity to SARS-CoV-2: the knowns and unknowns
    Sette, Alessandro
    Crotty, Shane
    NATURE REVIEWS IMMUNOLOGY, 2020, 20 (08) : 457 - 458
  • [47] Pre-existing immunity in human challenge studies of influenza transmission Reply
    Killingley, Ben
    Hayward, Andrew
    Enstone, Joanne E.
    Ferguson, Neil
    Oxford, John
    Nguyen-Van-Tam, Jonathan
    Booy, Robert
    LANCET INFECTIOUS DISEASES, 2012, 12 (10): : 744 - 745
  • [48] Long-lasting humoral and cellular memory immunity to vaccinia virus Tiantan provides pre-existing immunity against mpox virus in Chinese population
    Li, Min
    Guo, Yaxin
    Deng, Yao
    Gao, Wenhui
    Huang, Baoying
    Yao, Weiyong
    Zhao, Yingze
    Zhang, Qing
    Huang, Mengkun
    Liu, Maoshun
    Li, Lei
    Guo, Peipei
    Tian, Jinmin
    Wang, Xin
    Lin, Ying
    Gan, Jinxian
    Guo, Yuanyuan
    Hu, Yuechao
    Zhang, Jianing
    Yang, Xiaonan
    Shang, Bingli
    Yang, Mengjie
    Han, Yang
    Wang, Yalan
    Cong, Peilei
    Li, Mengzhe
    Chu, Qiaohong
    Zhang, Danni
    Wang, Qihui
    Zhang, Tong
    Wu, Guizhen
    Tan, Wenjie
    Gao, George F.
    Liu, Jun
    CELL REPORTS, 2024, 43 (01):
  • [49] THE IMPACT OF EMERGENCY SURGERY ON PATIENTS WITH PRE-EXISTING DISEASE
    SILVERSTEIN, ME
    MCGAVACK, TH
    WINFIELD, JM
    SURGICAL CLINICS OF NORTH AMERICA, 1955, 35 (02) : 319 - 333
  • [50] Lovastatin is not hepatotoxic to patients with pre-existing liver disease
    Avins, Andrew L.
    Manos, Michelle M.
    Levin, Theodore R.
    Ackerson, Lynn M.
    Zhao, Wei K.
    Murphy, Rosemary C.
    Watson, Douglas J.
    Hwang, Peggy May T.
    Replogle, Amy R.
    Levine, Jeffrey G.
    GASTROENTEROLOGY, 2006, 130 (04) : A595 - A595
12345